Desloratadine-API

• Inhibits dihydrofolate reductase to block folate metabolism and impede DNA synthesis. • Provides rapid therapeutic effects through intravenous, intramuscular, intra-arterial injection. • Widely used in oncology and autoimmune therapies to manage various conditions. • Proven to induce remission a...

• Platinum-based compound that forms DNA cross-links to disrupt cancer cell replication. • Clinically proven in colorectal and gastrointestinal malignancies through robust trials. • Administered via intravenous infusion, fitting into established chemotherapy regimens such as FOLFOX. • Clinical studies ...

• Stabilizes microtubules to obstruct cell division by preventing spindle disassembly. • Supported by extensive clinical evidence in treating breast, ovarian, lung, and other solid tumors. • Administered via intravenous infusion, integrating well with established chemotherapy regimens.

• Fluorouracil disrupts DNA synthesis by inhibiting thymidylate synthase, impairing tumor cell proliferation. • Proven efficacy across multiple cancers, including colorectal and breast malignancies, through comprehensive clinical studies. • Primarily administered via intravenous infusion. • Demonstrate...

• High-purity active pharmaceutical ingredient formulated for the production of abiraterone acetate dosage forms. • Effectively inhibits CYP17, contributing to reduced androgen synthesis in prostate cancer therapies. • Presented as a white to off-white crystalline powder that meets strict quality standa...

• High-purity active pharmaceutical ingredient designed for the manufacture of dasatinib-based formulations. • A potent multi-targeted tyrosine kinase inhibitor effective against BCR-ABL and Src family kinases. • Exhibits robust inhibitory activity, making it a critical component in treatments for CML a...

• High-quality active pharmaceutical ingredient used in the production of low molecular weight heparin formulations. • Exhibits reliable anticoagulant activity with a favorable pharmacokinetic profile for clinical applications. • Manufactured under stringent cGMP conditions to guarantee exceptional puri...

• High-purity active pharmaceutical ingredient developed for erlotinib-based formulations. • Potent inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, essential for targeting aberrant cancer cell signaling. • Supplied as a fine crystalline powder with excellent physicochemical sta...

• High-quality active pharmaceutical ingredient developed for fingolimod-based formulations. • Potent modulator of sphingosine-1-phosphate receptors, crucial for managing relapsing multiple sclerosis. • Manufactured under strict cGMP conditions to ensure consistent quality and batch-to-batch reproducibi...

• High-quality active pharmaceutical ingredient developed for gefitinib-based formulations. • Selective EGFR tyrosine kinase inhibitor designed to block aberrant cancer cell signaling. • Offered as a fine, crystalline powder with excellent purity and consistent physicochemical properties. • Manufacture...

• Premium-grade active pharmaceutical ingredient intended for imatinib-based formulations. • Selectively targets the BCR-ABL tyrosine kinase, crucial for managing chronic myelogenous leukemia and gastrointestinal stromal tumors. • Supplied as a highly purified crystalline powder with excellent physicoch...

• High-quality active pharmaceutical ingredient designed for lenalidomide hemihydrate formulations. • Manufactured under stringent cGMP conditions to ensure batch-to-batch reproducibility and high quality. • Extensively characterized using advanced analytical techniques such as HPLC, NMR, and LC-MS for ...